Epilepsy prevalence and severity predictors in MRI-identified focal cortical dysplasia

- 29% of children with an MRI-identified FCD did not have epilepsy.
- The prevalence of epilepsy and drug-resistant epilepsy was 71% and 33%, respectively.
- Lobar location predicted the likelihood of developing epilepsy.
- Family history of seizures predicted the likelihood of developing epilepsy.
- Age of seizure onset predicted the chance of developing drug-resistance.

ObjectivesTo determine the prevalence of epilepsy and drug-resistant epilepsy in pediatric patients with focal cortical dysplasia (FCD) identified by magnetic resonance imaging (MRI). To determine clinical and imaging differences between those with drug-resistant epilepsy, drug-responsive epilepsy, and no epilepsy among children with MRI-identified FCD.MethodsA keyword search of a hospital radiology database identified 97 study participants for inclusion in this retrospective study. Participants were included if they were under 18 years of age at time of database query and had an MRI between 2004 and 2013 showing FCD. Exclusion was based on imaging and clinical characteristics. Data was gathered using a chart review and supplemental questionnaire.ResultsIn this cohort of patients with imaging findings compatible with FCD, 29% had not developed epilepsy. The prevalence of epilepsy and drug-resistant epilepsy was 71.13% (95% C.I. = 61.05-79.89%) and 32.99% (95% C.I. = 23.78-43.27%), respectively. Patients with epilepsy were more likely to have temporal (p = 0.029) or frontal (p = 0.044) lobe lesions and a family history of seizures (p = 0.003) than those without epilepsy. Age of seizure onset was later in those with drug-responsive epilepsy than those with drug-resistant epilepsy (p = 0.0002). A later age of seizure onset (OR = 1.22, p = 0.0441, 95% C.I. = 1.00-1.486) and absence of developmental delay (OR = 3.624, p = 0.0497, 95% C.I. = 1.002-13.110) predicted a less severe epilepsy phenotype.ConclusionsPrevious studies have only assessed patient cohorts with FCD and epilepsy, limiting the data on “asymptomatic” or “atypically presenting” FCD. Identifying a surprisingly large, novel cohort of children with FCD that had not developed epilepsy helps define prognosis and inform clinical management of children with FCD on imaging.